Cordium Pharmaceuticals Pvt Ltd, a trusted global pharmaceutical exporter from India, supplies high-quality oncology medicines including Palbociclib 75 mg Capsules, a widely used CDK4/6 inhibitor in modern cancer therapy protocols.
We ensure regulated pharmaceutical export supply chains, secure packaging, and efficient global logistics to major international destinations including:
🌍 South Africa: Johannesburg, Cape Town, Pretoria, Durban, Port Elizabeth (Gqeberha), Bloemfontein, KwaZulu-Natal, East London, Nelspruit, Polokwane
🌍 USA: Washington, New York
🌍 UAE: Dubai, Abu Dhabi
🌍 UK: London
🌍 Asia: Singapore, Philippines
💊 Palbociclib 75 mg Capsules – Medical Overview
Palbociclib is an oral targeted therapy used primarily in the management of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer, usually in combination with endocrine therapy.
🧪 Usage (Indications)
Used in HR+/HER2- breast cancer
Often combined with letrozole, fulvestrant, or other hormonal therapies
Helps slow cancer cell growth by inhibiting CDK4/6 proteins
💊 Dosage Information (General Medical Guidance)
Standard treatment often starts at 125 mg once daily (21 days on / 7 days off cycle)
75 mg strength is generally used for:
Dose reduction due to side effects
Hepatic impairment or tolerance adjustment
Dosage must always be prescribed and supervised by an oncologist
⚠️ Do not self-medicate. Dosage varies based on patient condition, blood counts, and clinical response.
⚠️ Side Effects
Common side effects may include:
Low white blood cell count (neutropenia)
Fatigue and weakness
Nausea or vomiting
Hair thinning
Diarrhea or constipation
Mouth sores
Serious side effects (require medical attention):
Severe infections
Lung inflammation (rare)
Abnormal liver function tests
🚨 Precautions
Regular blood monitoring is required during therapy
Avoid use during pregnancy or breastfeeding
Inform doctor about liver or kidney conditions
Avoid strong CYP3A inhibitors or inducers unless prescribed
Not recommended without oncology supervision
🌐 Global Pharma Export Excellence – Cordium Pharmaceuticals
Cordium Pharmaceuticals Pvt Ltd ensures:
GMP-compliant pharmaceutical sourcing
Secure international packaging standards
Fast export logistics support
Reliable supply for hospitals, distributors & licensed importers
We support global oncology medicine distribution networks with a focus on quality, compliance, and timely delivery.
📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
We ensure regulated pharmaceutical export supply chains, secure packaging, and efficient global logistics to major international destinations including:
🌍 South Africa: Johannesburg, Cape Town, Pretoria, Durban, Port Elizabeth (Gqeberha), Bloemfontein, KwaZulu-Natal, East London, Nelspruit, Polokwane
🌍 USA: Washington, New York
🌍 UAE: Dubai, Abu Dhabi
🌍 UK: London
🌍 Asia: Singapore, Philippines
💊 Palbociclib 75 mg Capsules – Medical Overview
Palbociclib is an oral targeted therapy used primarily in the management of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer, usually in combination with endocrine therapy.
🧪 Usage (Indications)
Used in HR+/HER2- breast cancer
Often combined with letrozole, fulvestrant, or other hormonal therapies
Helps slow cancer cell growth by inhibiting CDK4/6 proteins
💊 Dosage Information (General Medical Guidance)
Standard treatment often starts at 125 mg once daily (21 days on / 7 days off cycle)
75 mg strength is generally used for:
Dose reduction due to side effects
Hepatic impairment or tolerance adjustment
Dosage must always be prescribed and supervised by an oncologist
⚠️ Do not self-medicate. Dosage varies based on patient condition, blood counts, and clinical response.
⚠️ Side Effects
Common side effects may include:
Low white blood cell count (neutropenia)
Fatigue and weakness
Nausea or vomiting
Hair thinning
Diarrhea or constipation
Mouth sores
Serious side effects (require medical attention):
Severe infections
Lung inflammation (rare)
Abnormal liver function tests
🚨 Precautions
Regular blood monitoring is required during therapy
Avoid use during pregnancy or breastfeeding
Inform doctor about liver or kidney conditions
Avoid strong CYP3A inhibitors or inducers unless prescribed
Not recommended without oncology supervision
🌐 Global Pharma Export Excellence – Cordium Pharmaceuticals
Cordium Pharmaceuticals Pvt Ltd ensures:
GMP-compliant pharmaceutical sourcing
Secure international packaging standards
Fast export logistics support
Reliable supply for hospitals, distributors & licensed importers
We support global oncology medicine distribution networks with a focus on quality, compliance, and timely delivery.
📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Keywords
